Filetype
Published 16 March 2020 Message from the LUDC Executive Board. Photo by CDC on Unsplash Dear Friends and colleagues,We are all now well aware that the COVID-19 pandemic is spreading fast in Sweden and around the world. There is a lot of information to digest. Some of this is factual and helpful, but there is also a great deal of poorly informed speculation, that risks promoting anxiety and panic.
https://www.ludc.lu.se/article/updates-covid-19 - 2025-08-09
Published 20 May 2020 A method that will quickly and easily detect diabetic neuropathy, nerve damage caused by high blood sugar, is under development. The aim is to identify individuals in the risk zone so that it is possible to initiate early treatment to prevent, or even reverse, the development. Neuropathy can be difficult to diagnose. It covers many different nerve types, can express itself in
https://www.ludc.lu.se/article/screening-reveals-early-nerve-damage - 2025-08-09
Published 27 March 2020 Article in The Conversation by Paul Franks, professor of genetic epidemiology and Peter M Nilsson, professor of internal medicine - epidemiology at Lund University. Photo by CDC on Unsplash A growing number of Swedish doctors and scientists are raising alarm over the Swedish government’s approach to COVID-19. Unlike its Nordic neighbours, Sweden has adopted a relatively rel
https://www.ludc.lu.se/article/sweden-under-fire-relaxed-coronavirus-approach-heres-science-behind-it - 2025-08-09
Published 27 April 2015 In type 2 diabetes, the body’s cells are unable to assimilate the essential hormone insulin which is produced in the beta cells of the pancreas. Exactly what is wrong with the beta cells in type 2 diabetes is the question to which Professor Erik Renström at Lund University Diabetes Centre is searching for an answer. After just over twenty years of successful research in the
https://www.ludc.lu.se/article/nordic-award-research-what-wrong-beta-cells-type-2-diabetes - 2025-08-09
Published 31 March 2020 Olle Melander, professor of Internal Medicine and consultant at Skåne University Hospital, has received the prestigious European Research Council’s (ERC) Advanced Grant of approximately SEK 25 million. Olle Melander. Photo: Mikael Risedal Olle Melander, Professor of Internal Medicine, does research on new preventive treatments for diabetes and cardiovascular disease.“It fee
https://www.ludc.lu.se/article/olle-melander-awarded-erc-advanced-grants - 2025-08-09
Published 27 March 2020 Oktawia Nilsson's doctoral thesis describes Apolipoprotein A-I (shortly named ApoA-I), the main protein of HDL also known as “the good” cholesterol. Based on the experiments performed in the scientific papers included in this thesis, we propose that ApoA-I can be used as a promising treatment for diabetes and cardiovascular diseases. However, some people with genetic predis
https://www.ludc.lu.se/article/apolipoprotein-i-good-player-dark-side - 2025-08-09
By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 5 April 2020 The outbreak of covid19 has made us go more virtual than ever. During Oktawia Nilssons doctoral defense her opponent was connected by Zoom, and so was her relatives who could follow the webinar from Poland. The only thing that has been postponed is the celebration… Oktawias opponent and her relatives joine
https://www.ludc.lu.se/article/doctoral-defense-corona-style - 2025-08-09
Published 16 April 2020 A new app to fight covid-19 in Sweden by tracking symtoms is on its way. Watch professor Paul Franks when he explains the idea behind it. Watch the video
https://www.ludc.lu.se/article/video-app-will-predict-risk-and-outbreak-coronavirus-sweden - 2025-08-09
Published 29 April 2020 Researchers at Lund University in Sweden have launched a free app to help map the spread of infection in Sweden and increase knowledge of the coronavirus. “Data from the app will give us a clearer picture of the development of the disease and why some people only experience mild symptoms while others get seriously ill and die”, says Paul Franks, professor of genetic epidemi
https://www.ludc.lu.se/article/covid-symptom-tracker-app-launched-sweden - 2025-08-09
Published 8 May 2020 Future Faculty is pleased to announce the 2020 Minerva Leadership Award winner: associate professor Malin Fex. A webinar with the winner is booked for the 25th of May, 14.30 - 15.00. More details about the webinar will be posted on the Future faculty website. Malin will provide a short presentation and will answer questions about her experience on academic leadership. The offi
https://www.ludc.lu.se/article/malin-fex-winner-2020-minerva-leadership-award - 2025-08-09
By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 29 May 2020 The POInT clinic at the Clinical Research Centre (CRC) in Malmö welcomes parents with their young children. One of the research nurses who sees them is Annika Björne Fors, who coordinates all sample-taking and appointments related to the study. The aim of the POInT study is to train the immune system to toler
https://www.ludc.lu.se/article/intersection-healthcare-and-academia - 2025-08-09
By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 28 May 2020 Research published in the research journal Diabetologia needs to meet a high standard of quality. Most of the manuscripts submitted are rejected. At the start of 2021, Hindrik Mulder, MD and professor at Lund University Diabetes Centre (LUDC), will take over as editor-in-chief of the journal. After just over
https://www.ludc.lu.se/article/hindrik-mulder-incoming-editor-chief-diabetologia - 2025-08-09
By sara [dot] liedholm [at] med [dot] lu [dot] se (Sara Liedholm) - published 3 June 2020 Lund University Diabetes Centre (LUDC) will join a new IMI project - SOPHIA - which will contribute to a more patient-centric and equitable narrative around obesity and its multiple impacts on individuals from both a social and medical perspective. The project will provide evidence-based classification of pre
https://www.ludc.lu.se/article/sophia-aims-improve-obesity-treatment-and-change-narrative-around-obesity - 2025-08-09
Published 1 December 2016 Using the CRISPR/Cas9 “gene scissors” researchers at Lund University Diabetes Centre in Sweden have managed to “turn off” an enzyme that proved to play a key role in the regulation of the diabetes-associated TXNIP gene. The results are decreased cell death and increased insulin production in the genetically modified pancreatic beta cells. In a recent study, researchers ha
Published 14 December 2016 Charlotte Ling, professor of epigenetics at the Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Sweden, has been awarded the European Research Council’s Consolidator Grant. The funding of EUR 2 million over five years will be used to develop new methods to improve prediction, prevention and treatment of type 2 diabetes. Charlotte Ling is a pion
https://www.ludc.lu.se/article/investments-epigenetics-combat-diabetes - 2025-08-09
Published 6 February 2017 BEAt-DKD (“Biomarker Enterprise to Attack Diabetic Kidney Disease”), a unique public private partnership funded by the Innovative Medicines Initiative (IMI), member companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Juvenile Diabetes Research Foundation (JDRF) and the state of Switzerland has announced the launch of a 5-year
https://www.ludc.lu.se/article/beat-dkd-innovative-medicines-initiative-project-precision-medicine-dkd - 2025-08-09
Published 5 March 2019 In his research in zebrafish, Olov Andersson of Karolinska Institutet strives to generate insulin-producing cells and new treatment methods for diabetes. This has led to his selection as a recipient of the Leif C. Groop award for outstanding research, awarded by the Lund University Diabetes Centre and sponsored by Novo Nordisk Sweden. "It is a quick process to generate genet
https://www.ludc.lu.se/article/prize-awarded-research-zebrafish-could-lead-new-treatments-diabetes - 2025-08-09
Published 4 April 2019 A two-days seminar gathered some 70 researchers from the University of Bergen, the Institute for Molecular Medicine in Finland (FIMM) and Lund University Diabetes Centre. - We wanted to strengthen the bonds that already exist and in the future create a Nordic network of metabolic researchers, says Ola Hansson who organized the meeting. Kay Prüfer from Max-Planck Institute in
https://www.ludc.lu.se/article/nordic-network-metabolic-researchers - 2025-08-09
Published 5 April 2019 In Skåne, newborn babies can be screened for type 1 diabetes and celiac disease (gluten intolerance). To raise awareness about the screening we will be running an information campain on all commuter trains and busses in Skåne during week 15 and 19. Screening för typ 1-diabetes och celiaki Children found to be at risk are eligable to participate in our prevention studies POIn
https://www.ludc.lu.se/article/screening-t1d-and-celiac-disease - 2025-08-09
Published 15 April 2019 The 3rd Joint EASD Islet Study Group and Beta-Cell Workshop gathered experts in islet cell biology - mainly beta cells - ranging from development to function and with a focus on both type 1- and type 2-diabetes. Top from left: Jonathan Esguerra, Lena Eliasson, Elaine Cowan, Clair Lyons, Amaya Lopez and Hindrik Mulder. In the front: Alexander Hamilton and Malin Fex. This yea
https://www.ludc.lu.se/article/3rd-joint-easd-islet-study-group-and-beta-cell-workshop - 2025-08-09
